| |
|
|
|
AzurRx BioPharma Inc.  
|
|
0.9 0 (0%) |
05-26 09:30 |
|
Open: |
0.92 |
Pre close: |
0.9 |
Target:
|
1.25
|
|
High: |
0.9 |
Low: |
0.9 |
Resistance:
|
1.07
1.25
|
|
Volume: |
1,398 |
Market Cap: |
25M |
Support:
|
0.76
0.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.91
 |
MACD |
MACD(12,26):
|
0.07  |
|
MA(20): |
0.77 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
0.83 |
Stochastic Oscillator |
%K(14,3):
|
64.99 |
|
MA(250): |
0.96 |
%D(3): |
71.69 |
|
Average Volume(K) |
3-Month: |
28361
|
52-Week |
High:
|
2.29 |
|
10-Days: |
32841 |
Low: |
0.37 |
|
RSI |
RSI(14):
|
65.67 |
Change(%): |
-58.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.638 |
Return on Equity (ttm) |
-548.4 |
Shares Out. (M) |
28.20 |
|
EPS Est. Current Year |
-0.850 |
Return on Assets (ttm) |
-95.3 |
Shares Float (M) |
24.69 |
|
EPS Est. Next Year |
-0.670 |
PEG Ratio |
0.00 |
% Held by Insiders |
17.79 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
5.11 |
|
Forward EPS |
22425564.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
85 |
|
Book Value (p.s.) |
0.110 |
EBITDA (p.s.) |
-0.443 |
P/E |
-1.41 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.18 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.70 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-6.77 |
P/CF |
-2.00 |
|
|
|
|
|
|
